Skip to main content
Premium Trial:

Request an Annual Quote

Genset and Algene Sign Alzheimer's Study Alliance

Premium

PARIS--Genset and Algene Biotechnologies of Montreal have formed a strategic alliance for research into Alzheimer's disease. Algene has amassed a collection of clinical samples from Alzheimer's patients in Quebec and, by applying its gene mapping and statistical analysis platforms to these samples, has identified several chromosomal regions suspected to contain genes associated with the disease.

Algene will license its proprietary gene mapping results and provide access to its existing Alzheimer's disease DNA collections exclusively to Genset. In turn, Genset will use its genomics technologies to generate proprietary markers, perform high-throughput genotyping of the samples, and apply its biostatistics and bioinformatics tools to analyze the resulting association data. Genset will also fund a one-year research program at Algene for further sample collection.

Filed under

The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.